Valvular Heart Disease Treatment-Global Market Status and Trend Report 2013-2023

Table of Contents

Chapter 1 Overview of Valvular Heart Disease Treatment

• 1.1 Definition of Valvular Heart Disease Treatment in This Report
• 1.2 Commercial Types of Valvular Heart Disease Treatment
  • 1.2.1 Cardiac Catheterization
  • 1.2.2 Electrocardiogram (ECG)
  • 1.2.3 Chest X-Ray
  • 1.2.4 Stress Test
  • 1.2.5 Others
• 1.3 Downstream Application of Valvular Heart Disease Treatment
  • 1.3.1 Hospital & Clinics
  • 1.3.2 Ambulatory Surgical Centers
  • 1.3.3 Research Institutes
• 1.4 Development History of Valvular Heart Disease Treatment
• 1.5 Market Status and Trend of Valvular Heart Disease Treatment 2013-2023
  • 1.5.1 Global Valvular Heart Disease Treatment Market Status and Trend 2013-2023
  • 1.5.2 Regional Valvular Heart Disease Treatment Market Status and Trend 2013-2023

Chapter 2 Global Market Status and Forecast by Regions

• 2.1 Market Development of Valvular Heart Disease Treatment 2013-2017
• 2.2 Production Market of Valvular Heart Disease Treatment by Regions
  • 2.2.1 Production Volume of Valvular Heart Disease Treatment by Regions
  • 2.2.2 Production Value of Valvular Heart Disease Treatment by Regions
• 2.3 Demand Market of Valvular Heart Disease Treatment by Regions
• 2.4 Production and Demand Status of Valvular Heart Disease Treatment by Regions
  • 2.4.1 Production and Demand Status of Valvular Heart Disease Treatment by Regions 2013-2017
  • 2.4.2 Import and Export Status of Valvular Heart Disease Treatment by Regions 2013-2017

Chapter 3 Global Market Status and Forecast by Types

• 3.1 Production Volume of Valvular Heart Disease Treatment by Types
• 3.2 Production Value of Valvular Heart Disease Treatment by Types
• 3.3 Market Forecast of Valvular Heart Disease Treatment by Types

Chapter 4 Global Market Status and Forecast by Downstream Industry

• 4.1 Demand Volume of Valvular Heart Disease Treatment by Downstream Industry
• 4.2 Market Forecast of Valvular Heart Disease Treatment by Downstream Industry

Chapter 5 Market Driving Factor Analysis of Valvular Heart Disease Treatment

• 5.1 Global Economy Situation and Trend Overview
• 5.2 Valvular Heart Disease Treatment Downstream Industry Situation and Trend Overview

Chapter 6 Valvular Heart Disease Treatment Market Competition Status by Major Manufacturers

• 6.1 Production Volume of Valvular Heart Disease Treatment by Major Manufacturers
• 6.2 Production Value of Valvular Heart Disease Treatment by Major Manufacturers
• 6.3 Basic Information of Valvular Heart Disease Treatment by Major Manufacturers
  • 6.3.1 Headquarters Location and Established Time of Valvular Heart Disease Treatment Major Manufacturer
  • 6.3.2 Employees and Revenue Level of Valvular Heart Disease Treatment Major Manufacturer
• 6.4 Market Competition News and Trend
  • 6.4.1 Merger, Consolidation or Acquisition News
  • 6.4.2 Investment or Disinvestment News
  • 6.4.3 New Product Development and Launch

Chapter 7 Valvular Heart Disease Treatment Major Manufacturers Introduction and Market Data

• 7.1 LivaNova PLC
  • 7.1.1 Company profile
  • 7.1.2 Representative Valvular Heart Disease Treatment Product
  • 7.1.3 Valvular Heart Disease Treatment Sales, Revenue, Price and Gross Margin of LivaNova PLC
• 7.2 Neovasc Inc.
  • 7.2.1 Company profile
  • 7.2.2 Representative Valvular Heart Disease Treatment Product
  • 7.2.3 Valvular Heart Disease Treatment Sales, Revenue, Price and Gross Margin of Neovasc Inc.
• 7.3 Medtronic
  • 7.3.1 Company profile
  • 7.3.2 Representative Valvular Heart Disease Treatment Product
  • 7.3.3 Valvular Heart Disease Treatment Sales, Revenue, Price and Gross Margin of Medtronic
• 7.4 B. Braun Melsungen AG
  • 7.4.1 Company profile
  • 7.4.2 Representative Valvular Heart Disease Treatment Product
  • 7.4.3 Valvular Heart Disease Treatment Sales, Revenue, Price and Gross Margin of B. Braun Melsungen AG
• 7.5 Abbott Laboratories
  • 7.5.1 Company profile
  • 7.5.2 Representative Valvular Heart Disease Treatment Product
  • 7.5.3 Valvular Heart Disease Treatment Sales, Revenue, Price and Gross Margin of Abbott Laboratories
• 7.6 Boston Scientific Corp.
  • 7.6.1 Company profile
  • 7.6.2 Representative Valvular Heart Disease Treatment Product
  • 7.6.3 Valvular Heart Disease Treatment Sales, Revenue, Price and Gross Margin of Boston Scientific Corp.
• 7.7 Symetis SA
  • 7.7.1 Company profile
  • 7.7.2 Representative Valvular Heart Disease Treatment Product
  • 7.7.3 Valvular Heart Disease Treatment Sales, Revenue, Price and Gross Margin of Symetis SA
• 7.8 Edwards Lifesciences Corporation
  • 7.8.1 Company profile
  • 7.8.2 Representative Valvular Heart Disease Treatment Product
  • 7.8.3 Valvular Heart Disease Treatment Sales, Revenue, Price and Gross Margin of Edwards Lifesciences Corporation
• 7.9 CryoLife Inc.
  • 7.9.1 Company profile
  • 7.9.2 Representative Valvular Heart Disease Treatment Product
  • 7.9.3 Valvular Heart Disease Treatment Sales, Revenue, Price and Gross Margin of CryoLife Inc.
• 7.10 Micro Interventional Devices
  • 7.10.1 Company profile
  • 7.10.2 Representative Valvular Heart Disease Treatment Product
  • 7.10.3 Valvular Heart Disease Treatment Sales, Revenue, Price and Gross Margin of Micro Interventional Devices
• 7.11 Braile Biomédica
  • 7.11.1 Company profile
  • 7.11.2 Representative Valvular Heart Disease Treatment Product
  • 7.11.3 Valvular Heart Disease Treatment Sales, Revenue, Price and Gross Margin of Braile Biomédica
• 7.12 Jenavalve Technology
  • 7.12.1 Company profile
  • 7.12.2 Representative Valvular Heart Disease Treatment Product
  • 7.12.3 Valvular Heart Disease Treatment Sales, Revenue, Price and Gross Margin of Jenavalve Technology
• 7.13 Lepu Medical Technology Co.
  • 7.13.1 Company profile
  • 7.13.2 Representative Valvular Heart Disease Treatment Product
  • 7.13.3 Valvular Heart Disease Treatment Sales, Revenue, Price and Gross Margin of Lepu Medical Technology Co.
• 7.14 TTK Healthcare Limited
  • 7.14.1 Company profile
  • 7.14.2 Representative Valvular Heart Disease Treatment Product
  • 7.14.3 Valvular Heart Disease Treatment Sales, Revenue, Price and Gross Margin of TTK Healthcare Limited
• 7.15 Colibri Heart Valve
  • 7.15.1 Company profile
  • 7.15.2 Representative Valvular Heart Disease Treatment Product
  • 7.15.3 Valvular Heart Disease Treatment Sales, Revenue, Price and Gross Margin of Colibri Heart Valve

Chapter 8 Upstream and Downstream Market Analysis of Valvular Heart Disease Treatment

• 8.1 Industry Chain of Valvular Heart Disease Treatment
• 8.2 Upstream Market and Representative Companies Analysis
• 8.3 Downstream Market and Representative Companies Analysis

Chapter 9 Cost and Gross Margin Analysis of Valvular Heart Disease Treatment

• 9.1 Cost Structure Analysis of Valvular Heart Disease Treatment
• 9.2 Raw Materials Cost Analysis of Valvular Heart Disease Treatment
• 9.3 Labor Cost Analysis of Valvular Heart Disease Treatment
• 9.4 Manufacturing Expenses Analysis of Valvular Heart Disease Treatment

Chapter 10 Marketing Status Analysis of Valvular Heart Disease Treatment

• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
  • 10.1.3 Marketing Channel Development Trend
• 10.2 Market Positioning
  • 10.2.1 Pricing Strategy
  • 10.2.2 Brand Strategy
  • 10.2.3 Target Client
• 10.3 Distributors/Traders List

Chapter 11 Report Conclusion

Chapter 12 Research Methodology and Reference

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources